G360-IIT: Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy (clinicaltrials.gov) - Sep 24, 2026 - P2 | N=5 | Terminated | Sponsor: Hackensack Meridian Health | N=108 ➔ 5 | Trial completion date: Apr 2027 ➔ Aug 2026 | Recruiting ➔ Terminated | Trial primary completion date: Apr 2027 ➔ Aug 2026; Slow Accrual
Circulating tumor DNA • Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Lung Cancer • Lung Non-Small Cell Squamous Cancer • Lung Non-Squamous Non-Small Cell Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • PD-L1
|